Zohydro
Product Images NDC 43376-210
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zohydro (NDC 43376-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zogenix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Percentage Improvement In Average Pain Intensity From Screening To Final Visit (Zohydro Extended Release Capsules 2)
Ndc 43376-210-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 10 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 3)
Ndc 43376-215-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 15 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 4)
Ndc 43376-220-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 20 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 5)
Ndc 43376-230-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 30 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 6)
Ndc 43376-240-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 40 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 7)
Ndc 43376-250-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 50 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 8)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.